Latest Innovation News

ABx Group and Core Refining have mutually terminated their licence agreement as ABx pivots to a more cost-effective and sustainable method for producing aluminium fluoride, advancing the ALCORE project into its continuous pilot phase in Tasmania.

De.mem Limited has secured a strategic distribution agreement with Singapore’s Firmbase Pte Ltd to penetrate key Asian markets, including China, Indonesia, and Japan, marking its first commercial sale in China’s burgeoning home water filtration sector.

Alcidion has secured its first contract in Wales with Hywel Dda University Health Board, deploying its Miya Precision Platform to enhance patient flow and clinical communication over five years.

Swift Networks Group has inked a three-year, $804,191 contract with Shell to provide its Swift Access platform and ongoing support for the Prelude FLNG facility, marking a significant expansion in its oil and gas sector footprint.

Breville Group Limited delivered a robust first half for FY25, posting double-digit revenue growth and a significant rise in net profit, underpinned by strong consumer demand and proactive inventory management to counter tariff risks.

Breville Group Limited reported a robust half-year performance with a 10.1% rise in revenue to nearly A$1 billion and a 16.1% jump in net profit, underpinning confidence in its premium appliance strategy.

CSL Limited reported a solid half-year performance with 5% revenue growth and a 7% rise in net profit, driven by strong demand in its Behring and Vifor segments despite challenges in Seqirus. The company reaffirmed its full-year NPATA guidance of 10-13%, signaling confidence in its operational momentum.

CSL Limited posted a robust half-year performance with NPATA rising 5% at constant currency, driven by strong growth in CSL Behring and CSL Vifor despite challenges in its influenza vaccine segment. The company reaffirmed its FY25 guidance, anticipating double-digit earnings growth.

CSL Limited reported a solid 5% revenue increase and 6% rise in net profit after tax for the half year ended December 2024, underpinned by robust performance in its plasma therapies business despite headwinds in its influenza vaccine segment.

Auswide Bank Ltd's shares have been suspended from trading following court approval of its acquisition by MyState Bank Limited, marking a significant consolidation in the Australian retail banking sector.

Gyder Surgical, backed by Hydrix Ventures, has secured FDA 510(k) clearance for its innovative GYDER Hip System, opening the door to the lucrative U.S. market and increasing Hydrix’s investment value.

Tasman Resources updates shareholders on Eden Innovations’ ongoing sale of a Georgia industrial property and the extension of its iBorrow financing facility, aiming to unlock value amid protracted negotiations.